Description
Key urinary metabolite of PGD2; represents approximately 1% and 4% of the infused radiolabeled dose in monkeys and humans, respectively
Formal name: 9α,11β,15S-trihydroxy-2,3-dinor-prosta-5Z,13E-dien-1-oic acid
Synonyms: 2,3-dinor-11-epi PGF2α|2,3-dinor-11β-PGF2α
Molecular weight: 326.4
CAS: 240405-20-3
Purity: ≥98%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway